TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 172 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $168 | -36.4% | 18,804 | +9.6% | 0.00% | -50.0% |
Q2 2023 | $264 | -37.9% | 17,163 | -9.2% | 0.00% | -33.3% |
Q1 2023 | $425 | +22.8% | 18,901 | +15.0% | 0.00% | 0.0% |
Q4 2022 | $346 | -99.9% | 16,440 | -7.6% | 0.00% | 0.0% |
Q3 2022 | $438,000 | +103.7% | 17,793 | +100.8% | 0.00% | +200.0% |
Q2 2022 | $215,000 | -26.4% | 8,859 | -21.8% | 0.00% | 0.0% |
Q1 2022 | $292,000 | -9.3% | 11,332 | +9.3% | 0.00% | 0.0% |
Q4 2021 | $322,000 | +59.4% | 10,367 | +24.5% | 0.00% | 0.0% |
Q3 2021 | $202,000 | – | 8,330 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
CM Management, LLC | 60,000 | $875,000 | 0.63% |
Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |